Thousands of cancer patients across England face an anxious wait for diagnosis and treatment, as NHS targets remain consistently out of reach despite years of effort to improve services, a stark new analysis warns.
The King's Fund report reveals that cancer waiting time targets have been under severe strain long before COVID-19 struck. The crucial 62-day target – ensuring 85% of patients begin treatment within two months of an urgent GP referral – hasn't been consistently met for several years. This means that for every 100 patients referred with suspected cancer, more than 15 are waiting longer than the recommended timeframe.
The pandemic has worsened an already challenging situation, creating substantial backlogs that the NHS continues to tackle. The combination of workforce shortages, insufficient diagnostic equipment, and overwhelming demand has created what the health think tank describes as a "perfect storm" for cancer services.
For patients, these delays carry real consequences. Early diagnosis remains one of the most important factors in successful cancer treatment, and any delay can potentially affect outcomes. However, it's important to emphasise that the NHS continues to prioritise the most urgent cases, and cancer treatment remains highly effective when caught early.
If you're experiencing concerning symptoms, don't delay seeking help. Contact your GP promptly or ring NHS 111 for guidance – early action is always the best approach.
The King's Fund calls for sustained, long-term investment to tackle these deep-rooted challenges. This includes expanding diagnostic capacity with more MRI and CT scanners, and crucially, recruiting and retaining specialist staff including oncologists, radiologists, and pathologists. Without these fundamental improvements, the report warns that timely cancer care will remain elusive.
Whilst NHS teams have worked tirelessly to restore services following the pandemic, the scale of the challenge in cancer care remains substantial. The report serves as an urgent reminder that sustained political commitment and adequate funding are essential to ensure patients receive the swift, high-quality cancer care they deserve.